- Home
- AVIR vs ALUB Comparison
AVIR vs ALUB Comparison
Compare AVIR & ALUB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$4.89
Company Overview
Basic Information| Metric | AVIR | ALUB |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 434.5M | 359.7M |
| IPO Year | 2020 | 2026 |
Fundamental Metrics
Financial Performance| Metric | AVIR | ALUB |
|---|---|---|
| Price | $4.89 | $10.05 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 330.7K | 24.4K |
| Earning Date | 05-11-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $351,367,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.78 | $9.91 |
| 52 Week High | $6.45 | $10.10 |
Technical Indicators
Market Signals| Indicator | AVIR | ALUB |
|---|---|---|
| Relative Strength Index (RSI) | 60.79 | 56.12 |
| Support Level | $4.14 | $9.97 |
| Resistance Level | $6.37 | $10.10 |
| Average True Range (ATR) | 0.21 | 0.01 |
| MACD | 0.08 | 0.00 |
| Stochastic Oscillator | 82.72 | 40.00 |
Price Performance
Historical Comparison AVIR
ALUB
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
About ALUB Alussa Energy Acquisition Corp. II Class A Ordinary Shares
Alussa Energy Acquisition Corp II is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.